Search research articles
Contact Us
Filters
Showing results (91-100 of 123) with videos related to
Page
of 13
Sort By:
Communications Medicine
|
June 9, 2026
Decreased amyloid-related structure-function coupling in preclinical Alzheimer's disease
Prithvi Arunachalam, Leonard Pieperhoff, Luigi Lorenzini, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Leonard Pieperhoff, Luigi Lorenzini, Mario Tranfa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 20, 2018
AMYPAD Diagnostic and Patient Management Study: Rationale and design
Giovanni B Frisoni, Frederik Barkhof, Daniele Altomare, et al.
CNS Drugs
|
December 1, 2025
Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional Trials
Susan Abushakra, P Murali Doraiswamy, John A Hey, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
July 13, 2019
Tackling gaps in developing life-changing treatments for dementia
Rui Mauricio, Caroline Benn, John Davis, et al.
Brain : a Journal of Neurology
|
August 14, 2020
Functional cognitive disorder: dementia's blind spot
Harriet A Ball, Laura McWhirter, Clive Ballard, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Leonard Pieperhoff, Luigi Lorenzini, Mario Tranfa, et al.
Journal of Global Health
|
January 2, 2020
Tackling dementia globally: the Global Dementia Prevention Program (GloDePP) collaboration
Kit Yee Chan, Davies Adeloye, Kwaku Poku Asante, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 14, 2020
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study
Isadora Lopes Alves, Lyduine E Collij, Daniele Altomare, et al.
The New England Journal of Medicine
|
March 9, 2012
Donepezil and memantine for moderate-to-severe Alzheimer's disease
Robert Howard, Rupert McShane, James Lindesay, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 123) with videos related to
Sort By:
Page
of 13
Communications Medicine
|
June 9, 2026
Decreased amyloid-related structure-function coupling in preclinical Alzheimer's disease
Prithvi Arunachalam, Leonard Pieperhoff, Luigi Lorenzini, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Leonard Pieperhoff, Luigi Lorenzini, Mario Tranfa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 20, 2018
AMYPAD Diagnostic and Patient Management Study: Rationale and design
Giovanni B Frisoni, Frederik Barkhof, Daniele Altomare, et al.
CNS Drugs
|
December 1, 2025
Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional Trials
Susan Abushakra, P Murali Doraiswamy, John A Hey, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
July 13, 2019
Tackling gaps in developing life-changing treatments for dementia
Rui Mauricio, Caroline Benn, John Davis, et al.
Brain : a Journal of Neurology
|
August 14, 2020
Functional cognitive disorder: dementia's blind spot
Harriet A Ball, Laura McWhirter, Clive Ballard, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Leonard Pieperhoff, Luigi Lorenzini, Mario Tranfa, et al.
Journal of Global Health
|
January 2, 2020
Tackling dementia globally: the Global Dementia Prevention Program (GloDePP) collaboration
Kit Yee Chan, Davies Adeloye, Kwaku Poku Asante, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 14, 2020
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study
Isadora Lopes Alves, Lyduine E Collij, Daniele Altomare, et al.
The New England Journal of Medicine
|
March 9, 2012
Donepezil and memantine for moderate-to-severe Alzheimer's disease
Robert Howard, Rupert McShane, James Lindesay, et al.
Page
of 13